A comprehensive view of Injectables/Infusions/IV Drips. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Packaging Industry Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

J&J drops out of hunt for Horizon Therapeutics, leaving Sanofi and Amgen to bid on what may be largest biotech acquisition of 2022; deal would include injectables Tepezza for thyroid eye disease, Krystexxa for chronic gout, Uplizna for autoimmune disease

Pfizer announces US$750.0M expansion at Kalamazoo, Michigan, pharma plant to increase manufacturing capacity of sterile injectable medications; expansion could lead to 300 new jobs at plant that current has about 3,000 employees

Canada to buy 15,000 treatment courses of Roche’s Actemra IV tocilizumab injectable to treat adult patients hospitalized with COVID-19; an estimated 429 out of 1,000 patients hospitalized with COVID-19 are eligible for tocilizumab

FDA withdraws emergency use authorization of Eli Lilly’s bebtelovimab injectable COVID-19 antibody therapy, citing the therapy is most likely ineffective against Omicron BQ.1 and BQ.1.1; Lilly had supplied 60,000 doses of the drug to US government in Q3

Roche receives Canadian approval for injectable Polivy polatuzumab vedotin to treat B-cell lymphoma; drug used in combination with Rituxan rituximab, cyclophosphamide, doxorubicin and immunosuppressive drug prednisone

Ask us about our Packaging Industry market view

Trending Chart

Interactive chart with headline count